Home / Fentanyl / United States
US ATC N01AH01 · updated 2 Nov 2026
Fentanyl shortage in United States
Is there a Fentanyl shortage in United States?
Yes. As of 2 Nov 2026, 20 Fentanyl products are reported short in United States, the first since 1 Jan 2012. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Austria, Belgium, Sweden, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01) | Fresenius Kabi USA, LLC | 1 Jan 2012 | not given | Not stated |
| US | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02) | Fresenius Kabi USA, LLC | 1 Jan 2012 | not given | Not stated |
| US | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05) | Fresenius Kabi USA, LLC | 1 Jan 2012 | not given | Not stated |
| US | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20) | Fresenius Kabi USA, LLC | 1 Jan 2012 | not given | Not stated |
| US | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50) | Fresenius Kabi USA, LLC | 1 Jan 2012 | not given | Not stated |
| US | Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22) | Hospira, Inc., a Pfizer Company | 1 Jan 2012 | not given | Not stated |
| US | Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31) limited | Hospira, Inc., a Pfizer Company | 1 Jan 2012 | not given | Increased demand Demand increase for the drug |
| US | Fentanyl Citrate, Injection, 2,500 mcg/50 mL (50 mcg/mL) Single Dose Glass Fliptop Vial (NDC 0409-9094-55) | Hospira, Inc., a Pfizer Company | 1 Jan 2012 | not given | Not stated |
| US | Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25) limited | Hospira, Inc., a Pfizer Company | 1 Jan 2012 | not given | Increased demand Demand increase for the drug |
| US | Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61) | Hospira, Inc., a Pfizer Company | 1 Jan 2012 | not given | Not stated |
| US | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11) | Fresenius Kabi USA, LLC | 1 Jan 2012 | not given | Not stated |
| US | Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28) limited | Hospira, Inc., a Pfizer Company | 1 Jan 2012 | not given | Increased demand Demand increase for the drug |
| US | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25) | Hikma Pharmaceuticals USA, Inc. | 20 Dec 2023 | not given | Not stated |
| US | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25) | Hikma Pharmaceuticals USA, Inc. | 20 Dec 2023 | not given | Not stated |
| US | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25) | Hikma Pharmaceuticals USA, Inc. | 20 Dec 2023 | not given | Not stated |
| US | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01) | Hikma Pharmaceuticals USA, Inc. | 20 Dec 2023 | not given | Not stated |
| US | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25) | Hikma Pharmaceuticals USA, Inc. | 20 Dec 2023 | not given | Not stated |
| US | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10) | Hikma Pharmaceuticals USA, Inc. | 20 Dec 2023 | not given | Other |
| US | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) | Hikma Pharmaceuticals USA, Inc. | 20 Dec 2023 | not given | Other |
| US | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05) | Hikma Pharmaceuticals USA, Inc. | 20 Dec 2023 | not given | Other |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).